LUMOSA THERAPEUTICS CO LTD has a total of 28 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, Brazil and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CINDA PHARMA AB, RC BIOTECHNOLOGIES INC and EHRENPREIS ELI D.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Brazil | 3 | |
#3 | Taiwan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Tien Yu-En | 17 |
#2 | Li Chan-Jung | 17 |
#3 | Chou David Chih-Kuang | 17 |
#4 | Kuo Shu-Wen | 15 |
#5 | Huang Jin-Ding | 10 |
#6 | Tsai Shin Jr | 6 |
#7 | Tsai Shin-Jr | 5 |
#8 | Chern Wendy Huang | 5 |
#9 | Li Chan Jung | 3 |
#10 | Tien Yu En | 3 |
Publication | Filing date | Title |
---|---|---|
US2021085747A1 | Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate | |
US2020030318A1 | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester | |
AU2019243571A1 | Compositions and methods for treating pruritus | |
US2016346275A1 | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester | |
CN106376232A | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester |